Failure of acute saralasin to reverse chronic hypertension in fetal lambs

Debra Anderson, N. D. Binder

    Research output: Contribution to journalArticle

    2 Citations (Scopus)

    Abstract

    Upper body arterial hypertension developed in 12 fetal lambs after chronic suprarenal aortic blood flow reduction. Sixty minutes after blood flow reduction, intravenous saralasin infusion was able to reduce upper body mean arterial blood pressure to control levels. Although saralasin infusion was able to decrease upper body arterial blood pressure after 1 day of hypertension, it was not able to return blood pressure to control levels. Three or more days later, saralasin was unable to cause a significant reduction in upper body arterial blood pressure. We conclude that, although the renin-angiotensin system has a role in maintaining the elevated blood pressure after ≥1 day of suprarenal aortic blood flow reduction, some other mechanism also participates. We have ruled out a role for changing blood volume, and our results suggest that an elevation of plasma catecholamines is not responsible. Some other pathway for fluid regulation available to the fetus may be responsible.

    Original languageEnglish (US)
    JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
    Volume260
    Issue number4 29/4
    StatePublished - 1991

    Fingerprint

    Saralasin
    Arterial Pressure
    Hypertension
    Blood Pressure
    Renin-Angiotensin System
    Blood Volume
    Intravenous Infusions
    Catecholamines
    Fetus

    Keywords

    • Angiotensin
    • Fetal blood pressure
    • Fetal hypertension

    ASJC Scopus subject areas

    • Physiology

    Cite this

    Failure of acute saralasin to reverse chronic hypertension in fetal lambs. / Anderson, Debra; Binder, N. D.

    In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 260, No. 4 29/4, 1991.

    Research output: Contribution to journalArticle

    @article{17407ce94a514fa882c85dbb8b42405c,
    title = "Failure of acute saralasin to reverse chronic hypertension in fetal lambs",
    abstract = "Upper body arterial hypertension developed in 12 fetal lambs after chronic suprarenal aortic blood flow reduction. Sixty minutes after blood flow reduction, intravenous saralasin infusion was able to reduce upper body mean arterial blood pressure to control levels. Although saralasin infusion was able to decrease upper body arterial blood pressure after 1 day of hypertension, it was not able to return blood pressure to control levels. Three or more days later, saralasin was unable to cause a significant reduction in upper body arterial blood pressure. We conclude that, although the renin-angiotensin system has a role in maintaining the elevated blood pressure after ≥1 day of suprarenal aortic blood flow reduction, some other mechanism also participates. We have ruled out a role for changing blood volume, and our results suggest that an elevation of plasma catecholamines is not responsible. Some other pathway for fluid regulation available to the fetus may be responsible.",
    keywords = "Angiotensin, Fetal blood pressure, Fetal hypertension",
    author = "Debra Anderson and Binder, {N. D.}",
    year = "1991",
    language = "English (US)",
    volume = "260",
    journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
    issn = "1931-857X",
    publisher = "American Physiological Society",
    number = "4 29/4",

    }

    TY - JOUR

    T1 - Failure of acute saralasin to reverse chronic hypertension in fetal lambs

    AU - Anderson, Debra

    AU - Binder, N. D.

    PY - 1991

    Y1 - 1991

    N2 - Upper body arterial hypertension developed in 12 fetal lambs after chronic suprarenal aortic blood flow reduction. Sixty minutes after blood flow reduction, intravenous saralasin infusion was able to reduce upper body mean arterial blood pressure to control levels. Although saralasin infusion was able to decrease upper body arterial blood pressure after 1 day of hypertension, it was not able to return blood pressure to control levels. Three or more days later, saralasin was unable to cause a significant reduction in upper body arterial blood pressure. We conclude that, although the renin-angiotensin system has a role in maintaining the elevated blood pressure after ≥1 day of suprarenal aortic blood flow reduction, some other mechanism also participates. We have ruled out a role for changing blood volume, and our results suggest that an elevation of plasma catecholamines is not responsible. Some other pathway for fluid regulation available to the fetus may be responsible.

    AB - Upper body arterial hypertension developed in 12 fetal lambs after chronic suprarenal aortic blood flow reduction. Sixty minutes after blood flow reduction, intravenous saralasin infusion was able to reduce upper body mean arterial blood pressure to control levels. Although saralasin infusion was able to decrease upper body arterial blood pressure after 1 day of hypertension, it was not able to return blood pressure to control levels. Three or more days later, saralasin was unable to cause a significant reduction in upper body arterial blood pressure. We conclude that, although the renin-angiotensin system has a role in maintaining the elevated blood pressure after ≥1 day of suprarenal aortic blood flow reduction, some other mechanism also participates. We have ruled out a role for changing blood volume, and our results suggest that an elevation of plasma catecholamines is not responsible. Some other pathway for fluid regulation available to the fetus may be responsible.

    KW - Angiotensin

    KW - Fetal blood pressure

    KW - Fetal hypertension

    UR - http://www.scopus.com/inward/record.url?scp=0025735193&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0025735193&partnerID=8YFLogxK

    M3 - Article

    C2 - 2012252

    AN - SCOPUS:0025735193

    VL - 260

    JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

    JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

    SN - 1931-857X

    IS - 4 29/4

    ER -